| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |